Over the latest trailing 12-month period, total return cagr is -97.98%. The comparable SPY value is +16.94%. Year-to-date total return is -96.84%. Total return includes price appreciation and reinvested dividends.
Over the past 12 months, Total Return CAGR is -97.98%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Jupiter Neurosciences, Inc. (JUNS)
Total Return growth vs the same calendar quarter one year earlier, last 5 comparable quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-05): $0.59.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | -96.84% |
| 2025 | -90.47% |
| Period | Period End | QoQ Return | YoY Return |
|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-05 | N/A | -96.8% |
| Q3 2026 | 2026-09-30 | -84.8% | -98.2% |
| Q2 2026 | 2026-06-30 | -43.1% | -79.0% |
| Q1 2026 | 2026-03-31 | -63.1% | -38.3% |
| Q4 2025 | 2025-12-31 | -42.0% | -90.5% |
| Q3 2025 | 2025-09-30 | +72.5% | N/A |
| Q2 2025 | 2025-06-30 | +67.2% | N/A |
| Q1 2025 | 2025-03-31 |
| -94.3% |
| N/A |
| Q4 2024 | 2024-12-31 | N/A | N/A |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
